Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
1 SYNOPSYS PROFORMA FOR REGISTRATION OF SUBJECT FOR DISSERTATION Ms. GEETHU.R FIRST YEAR M.SC (NURSING) MEDICAL SURGICAL NURSING YEAR 2011-2013 ADITYA COLLEGE OF NURSING # 12, KOGILU MAIN ROAD, YELAHANKA BANGALORE – 560 064 2 RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES BANGALORE, KARNATAKA SYNOPSYS PROFORMA FOR REGISTRATION OF SUBJECT FOR DISSERTATION 1. 2. 3. 4. 5. Ms. GEETHU.R NAME OF THE CANDIDATE AND 1ST YEAR M.Sc. (NURSING) ADITYA COLLEGE OF ADDRES NURSING, #12 KOGILU MAIN ROAD, YELAHANKA, BANGALORE – 560 064 ADITYA COLLEGE OF NAME OF THE INSTITUTION NURSING, BANGALORE560064 COURSE OF THE STUDY AND 1ST YEAR M.Sc. (NURSING), MEDICAL SURGICAL SUBJECT NURSING DATE OF ADMISSION TO THE 15/06/2011 COURSE “ A STUDY TO EVALUATE THE EFFECTIVENESS OF TITLE OF THE STUDY POSTURAL DRAINAGE ON EXPECTORATION OF MUCUS FROM AIRWAY’S AMONG PATIENT WITH PNEUMONIA IN SELECTED HOSPITALS AT BANGALORE..” 3 6. BRIEF RESUME OF THE INTENDED WORK INTRODUCTION The Pneumonia are the infectious diseases affecting the Lower Respiratory tract (LRT)which includes trachea, bronchi, bronchioles, alveolar ducts and alveolar sacs. Most of the acute and chronic diseases affecting these parts of the lungs induce lots of mucus to be secreted, which gets impacted within the lungs and unable to be expectorated, will lead to structural and physiological damage of the lungs. Among the pneumonia’s, the most common and important superlative diseases are tuberculosis, bronchiectasis, chronic bronchitis, lung abscess, and cystic fibrosis and others.1 People with infectious pneumonia often have a productive cough, fever accompanied by shaking chills, shortness of breath, sharp or stabbing chest pain during deep breaths, confusion, and an increased respiratory rate. In the elderly, confusion may be the most prominent symptom. The typical symptoms in children under five are fever, cough, and fast or difficult breathing. Fever, however, is not very specific, as it occurs in many other common illnesses, and may be absent in those with severe disease or malnutrition. Additionally, a cough is frequently absent in children less than 2 months old. More severe symptoms may include: central cyanosis, decreased thirst, convulsions, persistent vomiting, or a decreased level of consciousness.2 Some causes of pneumonia are associated with classic, but non-specific, clinical characteristics. Pneumonia caused by Legionella may occur with abdominal pain, diarrhea, or confusion, while pneumonia caused by Streptococcus pneumonia is associated with rusty colored sputum, and pneumonia caused by Klebsiella may have bloody sputum often described as "currant jelly."3 4 Typically, oral antibiotics, rest, simple analgesics, and fluids are sufficient for complete resolution. However, those with other medical conditions, the elderly, or those with significant trouble breathing may require more advanced care. If the symptoms worsen, the pneumonia does not improve with home treatment, or complications occur, hospitalization may be required. Worldwide, approximately 7–13% of cases in children result in hospitalization while in the developed world between 22–42% of adults with community acquired pneumonia is admitted. The CURB-65 score is useful for determining the need for admission in adults. If the score is 0 or 1 people can typically be managed at home, if it is 2 a short hospital stay or close follow up is needed, if it is 3–5 hospitalization is recommended. In children those with respiratory distress or oxygen saturation's of less than 90% should be hospitalized. The utility of chest physiotherapy in pneumonia has not yet been determined. Over the counter cough medicine has not been found to be effective.4 Because pneumonia affects the lungs, people with pneumonia often have difficulty breathing, sometimes to the point where mechanical assistance is required. Non-invasive breathing assistance may be helpful, such as with a bi-level positive airway pressure machine. In other cases, placement of an endotracheal (breathing tube) may be necessary, and a ventilator may be used to help the person breathe.5 Pneumonia can also cause respiratory failure by triggering acute respiratory distress syndrome (ARDS), which results from a combination of infection and inflammatory response. The lungs quickly fill with fluid and become very stiff. This stiffness, combined with severe difficulties extracting oxygen due to the alveolar fluid, creates a need for mechanical ventilation.6 5 Pneumonia places a considerable strain on the health budget and are generally more serious than upper respiratory infections. Since 1993 there has been a slight reduction in the total number of deaths from Pneumonia. However in 2002 they were still the leading cause of deaths among all infectious diseases, and they accounted for 3.9 million deaths worldwide and 6.9% of all deaths that year.7 As, in case of bronchiectasis, chronic bronchitis, pulmonary tuberculosis, the condition and changes are irreversible, the treatment whatever we give is symptomatic and temporary and if at all any patients needs permanent relief he has to sacrifice a part of his lung, which is damaged, by surgical intervention. This reduces lung volumes, capacity, and reduces the oxygen saturation of blood and increases the complications like hemoptysis, empyema and others. This not only disturbs the patient’s life style but also it reduces the productivity of the patient in terms of employment and income generation.5 Instead of that, if a patient is subjected to postural drainage to drain the mucus / sputum out of lungs / bronchial tree, it reduces the frequent attacks of infections, decreases the breathing difficulty, increases the air flow, improves the lung volumes, reduces the cost of drug therapy and even it can postpone the need for surgical intervention.4 Various studies on postural drainage have shown the above fact that it clears the lungs, so that good air entry will occur, reaching the alveolar level where the oxygen exchange occurs. In most of the studies, postural drainage is combined with various other methods of chest physiotherapy. In some other studies, it is combined with other modalities of treatment like heat therapy, positive expiratory pressure therapy, and there 6 are many other studies where postural drainage compared with other modalities of therapies to clear the airways.4 There are studies to evaluate the effectiveness of postural drainage to clear the airway in term of amount of expectoration of sputum in cases of Bronchiectasis, chronic bronchitis, lung abscess, pulmonary tuberculosis patients, who are having mild to moderate symptoms. 6.1 NEED FOR THE STUDY The lower respiratory tract diseases are the conditions, where the lung undergoes reversible to irreversible damage because of recurrent pulmonary infections. The repair of lung parenchyma occurs with cavitations, fibrosis of bronchi. The lung parenchyma is further damaged with loss of drainage mechanism of the various mucoidal fluids which are formed within the alveoli and bronchi. As repeated infections occur, the naturally occurring cilia, and the regular drainage assisting mechanism is lost. This un-drained mucus accumulation gets secondarily infected, very commonly, which makes the life of such patients miserable.8 As, in case of bronchiectasis, chronic bronchitis, pulmonary tuberculosis, the condition and changes are irreversible, the treatment whatever we give is symptomatic and temporary and if at all any patients needs permanent relief he has to sacrifice a part of his lung, which is damaged, by surgical intervention. This reduces lung volumes, capacity, and reduces the oxygen saturation of blood and increases the complications like hemoptysis, empyema and others. This not only disturbs the patient’s life style but also it reduces the productivity of the patient in terms of employment and income generation.9 7 Indian Information The Prevalence of Chronic Lower Respiratory diseases is estimated to be 32 million including 15 million undiagnosed, which comes to Prevalence Rate approximately 1 in 8 or 11.76%. Undiagnosed prevalence rate of pneumonia’s is approximately 1 in 18 or 5.51%.10 According to CDC- centre for communicable diseases, Deaths from Chronic lower respiratory diseases are 124,181 annual deaths (5.2% of total deaths) (CDC/1999). 5th top cause of death in 1999 is "Chronic Lower Respiratory Disease" in India (CDC).10 Extrapolation of Prevalence of Chronic Respiratory diseases in India is 125,302,421 and undiagnosed prevalence is 58,735,509 among the 1,065,070,607 population studied. Worldwide Information During 1993 and 1994, the Hospital Infection Society conducted its Second National Prevalence Survey of infections in patients in British hospitals. The prevalence rates for hospital-acquired (HA) and community-acquired (CA), Pneumonia (Pneumonia) were 2.4% and 6.1%, respectively; this shows an increase over that reported in the First National Prevalence Study. The prevalence rate of HA infections for ventilated patients were 18.6%. The prevalence was greater in males, odds ratio (OR, 95% CI) for HAPneumonia (1.4, 1.1-1.6) and CA-Pneumonia (1.2, 1.1-1.3) than in females. In the case of both HA-Pneumonia and CA-Pneumonia, there was an increase in prevalence in patients with age >75 years, (HA-Pneumonia 1.7, 1.3-2.2; CA-Pneumonia 1.7, 1.0-2.7). Results of multivariable logistic regression analysis showed an increased risk of HA-Pneumonia in patients who had a nasogastric tube (3.6, 2.3-3.6), were ventilated (2.3, 1.6-3.2), trauma 8 patients (2.2, 1.5-3.0), chronic obstructive airway disease (COAD), (1.9, 1.5-2.3), a tracheostomy (1.9, 1.3-2.7), prior blood transfusion (1.5, 1.2-1.8), smokers (1.4, 1.1-1.6) or on systemic corticosteroid therapy (OR 1.3, 1.1-1.6). Community-acquired Pneumonia were positively associated with cystic fibrosis (33.7, 19.1-59.3), HIV (9.8, 6.5-14.8), COAD (4.8, 3.8-4.8), systemic corticosteroid therapy (2.5, 2.2-2.8), tracheostomy (1.8, 1.1-2.9), males (1.2, 1.1-1.3) and smoking (1.2, 1.1-1.4).11 According to the World Health Organization (WHO), nearly 2 billion people— one third of the world's population—have been exposed to the tuberculosis pathogen. Annually, 8 million people become ill with tuberculosis, and 2 million people die from the disease worldwide. 10 AS PER GLOBAL TUBERCULOSIS CONTROL - EPIDEMIOLOGY, STRATEGY, FINANCING WHO REPORT 2009, WHO/HTM/TB/2009.411, THERE WERE AN ESTIMATED 9.27 MILLION INCIDENT CASES OF TB IN 2007. THIS IS AN INCREASE FROM 8.3 MILLION CASES IN 2000 AND 6.6 MILLION CASES IN 1990. 10 The five countries that rank first to fifth in terms of total numbers of cases in 2007 are India (2.0 million), China (1.3 million), Indonesia (0.53 million), Nigeria (0.46 million) and South Africa (0.46 million). The average prevalence of all forms of tuberculosis in India is estimated to be 5.05 per thousand, prevalence of smear positive cases 2.27 per thousand and average annual incidence of smear-positive cases at 84 per 1,00,000 annually.11 9 6.2 REVIEW OF LITERATURE According to Burns (1997), the literature review is an essential component of the research as it aids researcher in formulating the research plan. By definition, the review of literature is broad, comprehensive, in-depth, systematic and critical, audiovisual material and personal communication. The primary purpose of the literature review is to give broad background knowledge or understanding of limitation that is available related to research problem of interest. It is also help the researcher to conduct his or her actual study. The literature review include both research and non research literature.21 For the present study the review of literature is organized under the following headings. 1. Literature related to prevalence of pneumonia 2. Literature related to management of pneumonia 3. Literature relate to effectiveness of postural drainage on expectoration of mucus from airway’s 1. Literature related to prevalence of pneumonia Janet S.M., (2000), conducted a study o obtain quantitative information from published data on the association between environmental tobacco smoke (ETS) exposure and the prevalence of serious Pneumonia in infancy and early childhood. The results of community and hospital studies are broadly consistent and show that the child of a parent who smokes is at approximately twice the risk of having a serious respiratory tract infection in early life that requires hospitalization.12 M. Lanari MD, (2002), this study was designed to collect data on the prevalence of respiratory syncytial virus (RSV) infection in Italy in infants hospitalized for Pneumonia. 10 Thirty-two centers throughout Italy participated in the study. Over a 6-month period (November 1, 1999 to April 30, 2000), they evaluated all children < 2 years of age hospitalized for Pneumonia. The collected data show that, in Italy, RSV is an important cause of Pneumonia in infants. Gestational age, birth order, birth weight, and exposure to tobacco smoke affected the prevalence and severity of RSV-related lower respiratory tract disease.13 Gabi Schulgen, (2000), conducted a study to assess the Prevalence and Risk Factors for Nosocomial Pneumonia in German Hospitals. The study included 14,966 patients in 72 representatively selected hospitals with departments of general medicine, surgery, obstetrics, gynecology, and intensive care units (ICU). The result showed that The overall prevalence of hospital-acquired pneumonia was 0.72% with the highest rate in hospitals with more than 600 beds (1.08%) and among the patients on intensive care units (9.00%). Ventilator-associated Pneumonia rates were highest in patients on ICUs (13.27).14 Nino Khetsuriani, (2006), conducted a study to assess Prevalence of viral respiratory tract infections in children with asthma. The aim of the study was to determine the prevalence of respiratory tract infection in children with asthma. Respiratory specimens from children aged 2 to 17 years with asthma exacerbations (case patients, n = 65) and with well-controlled asthma (control subjects, n = 77), frequency matched by age and season of enrollment, were tested for rhinoviruses, enteroviruses, respiratory syncytial virus, etc. this study revealed that Symptomatic rhinovirus infections are an important contributor to asthma exacerbations in children.15 11 M.C Kelsey, (2008), the Hospital Infection Society conducted its Second National Prevalence Survey of infections in patients in British hospitals. The prevalence rates for hospital-acquired (HA) and community-acquired (CA), Pneumonia were 2.4% and 6.1%, respectively; this shows an increase over that reported in the First National Prevalence Study.16 Carme Puig, (2008), conducted a study to evaluate Incidence and risk factors of lower respiratory tract illnesses during infancy in a Mediterranean birth cohort. The objective of the study is to investigate the incidence rate, viral respiratory agents and determinants of lower respiratory tract illnesses (pneumonia) in infants younger than 1 year. A total of 487 infants were recruited at birth for the Asthma Multicenter Infant Cohort Study in Barcelona (Spain). Cases of Pneumonia were ascertained through an active register including a home visit and viral test in nasal lavage specimens during the first year of life. This study showed that Viral Pneumonia is frequent in infants younger than 1 year of age and there is an inter-relationship between maternal asthma, siblings, breast feeding and socioeconomic status.17 2. Literature related to management of pneumonia C. Raherison, (2007), conducted a study on the management of Pneumonia in patients aged 15–65 yrs by general practitioners (GPs) in France. To obtain real-time data recording, practitioners were required to submit an anonymous copy of their drug prescriptions. They were then interviewed over the telephone. This study demonstrates the Pneumonia encountered by general practitioners is usually mild. However, antibiotic prescription was more systematic than in previous studies and the prescription of nonspecific symptomatic treatments was twice as frequent.18 12 Laurent Kaiser, (2000) conducted a study to assess the Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and Hospitalizations. he aim of this study was to assess the effect of oseltamivir treatment on the incidence of LRTCs leading to antibiotic treatment and hospitalizations following influenza illness. They analyzed prospectively collected data on LRTCs and antibiotic use from 3564 subjects (age range, 13-97 years) with influenzalike illness enrolled in 10 placebo-controlled, double-blind trials of oseltamivir treatment. This study showed that Oseltamivir treatment of influenza illness reduces LRTCs, antibiotic use, and hospitalization in both healthy and "at-risk" adults.19 Matthias Briel, (2008), Procalcitonin-Guided Antibiotic Use vs. a Standard Approach for Acute Respiratory Tract Infections in Primary Care. Fifty-three primary care physicians recruited 458 patients, each patient with an acute respiratory tract infection and, in the physician's opinion, in need of antibiotics. Patients were centrally randomized to either a procalcitonin-guided approach to antibiotic therapy or to a standard approach. This study revealed that as an adjunct to guidelines, procalcitoninguided therapy markedly reduces antibiotic use for acute respiratory tract infections in primary care without compromising patient outcome.20 E. Michael Sarrell, (2002), conducted a study to assess the effectiveness of Nebulization of 3% Hypertonic Saline Solution Treatment in Ambulatory Children With Viral Bronchiolitis Decreases Symptoms. The objective of the study was to determine the utility of inhaled hypertonic saline solution to treat ambulatory infants with viral bronchiolitis. Sixty-five ambulatory infants (mean ± SD age, 12.5 ± 6 months) with viral bronchiolitis received either of the following: inhalation of 0.5 mL (5 mg) terbutaline 13 added to 2 mL of 0.9% saline solution. This therapy was repeated three times every day for 5 days. They conclude that in nonasthmatic, nonseverely ill ambulatory infants with viral bronchiolitis, aerosolized 3% saline solution plus 5 mg terbutaline is effective in decreasing symptoms as compared to 0.9% saline solution plus 5 mg terbutaline.21 Brenda M,(2003) conducted a study to assess the effectiveness of Chest physiotherapy in Adult with pneumonia. We aimed to compare the effectiveness of standard postural drainage chest physiotherapy (SPT) with a modified physiotherapy regimen without head-down tilt (MPT) in Adult with pneumonia. Twenty newly diagnosed Adult with pneumonia (mean age, 25 yrs; range, 50yrs) were randomized to SPT or MPT. Parents kept a detailed symptom and treatment diary for the following 12 months. Serial chest radiographs, taken at diagnosis, 12 months, 2½ years, and 5 years after diagnosis, were assessed using the Brasfield score. This study revealed that standard postural drainage chest physiotherapy (SPT) is more effective for reducing the symptoms of pneumonia.22 Chris L. Kjolhede , (2000), conducted a study to assessed the effectiveness of vitamin A as adjuvant treatment for Pneumonia. The objective of the study was to To test the efficacy of a high dose of vitamin A as adjuvant treatment for radio graphically confirmed cases of acute Pneumonia (ALRI). Sequential sample of 263 patients vaged 3o to 40 years, identified in the emergency departments and admitted to the hospital in Guatemala City. Vitamin A (200,000 IU) or placebo in addition to standard treatment for ALRI which included antibiotics, oxygen, bronchodilators, and intravenously 14 administered solutions. This study showed that Vitamin A administration is very effective in reducing the symptoms of pneumonia.23 3. Literature relate to effectiveness of postural drainage on expectoration of mucus from airway’s J E Patterson, (2007), conducted a study to assess the effectiveness of postural drainage. The purpose of this study was to compare the efficacy of the test of incremental respiratory endurance (TIRE) with active cycle of breathing techniques (ACBT) [incorporating postural drainage (PD) and vibration] as methods of airway clearance in adults with bronchiectasis. :A randomized crossover study in which a single session of ACBT (incorporating PD and vibration) was compared to a single session of TIRE was carried out in 20 patients (14 female) with stable, productive bronchiectasis. This study concluded that ACBT (incorporating PD and vibration) is a more effective method of airway clearance in bronchiectasis than TIRE during single treatment sessions.24 B.A. Webber, (2003), conducted a study to assess the Effects of postural drainage, incorporating the forced expiration technique, on pulmonary function in cystic fibrosis. Detailed pulmonary function tests were performed on 12 patients with cystic fibrosis (CF) before and after 3 days treatment with postural drainage incorporating the forced expiration technique. The results following treatment showed a statistically significant improvement in FEV1 (P<0.001), FVC (P<0.001), PEFR (P<0.001), PIFR (P<0.001), and VEmax50 (P<0.025). The study demonstrates objective benefit from this form of physiotherapy in cystic fibrosis patients with copious bronchial secretions.25 John W. Wong,, (2000), conducted Aanoninvasive, radionuclide imaging technique for measuring the rate of mucus clearance in the trachea (RT), was used to study gravitational effects on mucus clearance in 13 patients with cystic fibrosis (CF), 15 average age 17 years; 7 normal, nonsmoking adults, average age 26 years; and a normal subject who was recovering from an acute upper respiratory tract infection (URTI). The results of the study indicate that the force of gravity can be a major influence on tracheal mucus clearance in CF and URTI subjects. This conclusion supports the use of postural drainage as an effective form of therapy in patients with cystic fibrosis.26 J.A. Pryor, (2010), conducted a study postural drainage and percussion: Airway clearance in people with cystic fibrosis. Seventy-five people with cystic fibrosis entered the prospective, randomized controlled trial of these five different ACTs. The primary outcome measure was forced expiratory volume in one second (FEV1). Secondary outcome measures included exercise capacity and health related quality of life. Using intention to treat, data were available on 65 subjects at the end of the study period. There were no statistically significant differences among the regimens in the primary outcome measurement.27 16 6.3(A) STATEMENT OF THE PROBLEM “A study to evaluate the effectiveness of postural drainage on expectoration of mucus from airway’s among patients pneumonia in selected hospitals at Bangalore. 6.4(B) OBJECTIVES OF THE STUDY 1. To assess the pre-test ability of expectoration of mucus from airways in patients suffering with pneumonia. 2. To evaluate effectiveness of postural drainage on expectoration of sputum from airways in patients with pneumonia. 3. To find out association between postural drainage on expectoration of mucus from airway among patients with pneumonia with selected demographical variables. 6.5(C )OPERATIONAL DEFINITION Effectiveness: It refers to the extent to which the teaching programme had brought about the result intended and measured in terms of significant knowledge gained in posttest. Postural drainage: It is a type of chest physiotherapy which is pertained to the position applied for the systematic withdrawal of fluids and discharges from cavities. It utilizes the gravity of earth for the drainage of fluids or discharges like mucus. Expectoration of Mucus The act of ejecting phlegm or mucus from the throat or lungs, by coughing, hawking, and spitting. 17 Pneumonia It refers to an infection of the lungs that is caused by bacteria, viruses, fungi, or parasites. It is characterized primarily by inflammation of the alveoli in the lungs or by alveoli that are filled with fluid (alveoli are microscopic sacs in the lungs that absorb oxygen). 6.6(D) RESEARCH HYPOTHESIS H1: There is significant relationship between the postural drainage and expectoration of mucus from airway. H2: There is significant difference between expectoration of mucus from airway before and after giving postural drainage in patients with pneumonia. H3: There is a significant association between performances of postural drainage with selected demographic variables. 6.7(E) LIMITATION The study is limited to the age group 15 to 55 years. The sample size was limited to 60 male and female persons. The study is limited to 6 weeks only. The study was conducted in selected hospital only. 6.8 ASSUMPTIONS 1. Regular chest physiotherapy will improve air entry in to the lungs and air way clearance. 2. Sputum expectoration will improve following postural drainage. 3. PEFR will improve following postural drainage. 18 7. MATERIALS AND METHODS This chapter gives a description of the research approach, research design, variables, the setting of the study, population, sampling, research tool, methods of data collection and plan for data analysis. 7.1 Sources of data Data will be collected from patient with pneumonia admitted in selected hospitals at Bangalore. 7.2 Methods of data collection I. Research design Quasi experimental method II. Research approach Evaluative approach. III. Research variables a. Independent variables Independent variables are the variable that stand alive and is not dependent on any other variables. In present study the independent variable is postural drainage 19 b. Dependent variables In this study the dependent variable refers to sputum production, PEFR of the patient c. Demographic variables Characteristics of patients such as Age, educational status, socioeconomic status and income. IV. Setting Study is planned to conduct in selected hospitals at Bangalore.. V. Population The patient with Pneumonia admitted in selected hospitals at Bangalore. VI. Sample The patient with Pneumonia admitted in selected hospitals at Bangalore.. For pilot study sample size will be 6. For main study the sample size will be 60. VII. criteria for sample selection a) Inclusion criteria Patient with Pneumonia admitted in select hospitals at Bangalore. Patient with Pneumonia who can communicate freely in Kannada or English. Male and female Patients who are between 15 to 55 years age group. The patients who are diagnosed as pneumonia. The patients who are expectorating more than 30 ml per day sputum. 20 b) Exclusion criteria Patient who are not willing to participate in the study The patient who are under the age of 15 years Patients who suffer with hemoptysis Patients who have sputum positive for Mycobacterium tuberculosis. Patients who have associated pulmonary conditions like large Pneumothorax, large pleural effusion, empyema Patients who had recent myocardial infarction, cardiac arrhythmias, severe hypertension, and cardiac surgery. VIII. Sampling Technique Non probability convenience sampling technique. IX. Tool for data collection SECTION I Demographic Data Demographic data included age, sex, educational status, income. SECTION II 1. Change in sputum production: Sputum production in an optimally hydrated patient with more than 25 ml/day when compared with base line sputum production after postural drainage therapy. 21 Scoring card for the sputum collection (applicable in both pre and post test collection of sputum):Amount of sputum collected Points Up to 0 to 50 ml 01 50 ml to 100ml 02 100ml to 150ml 03 150ml to 200ml 04 More than 200ml 05 2. PEFR (Peak Expiratory flow rate): The patient was asked to sit and take a deep breath and advised to blow forcefully through the mouth piece of peak flow meter at least for 3 times with an interval of 30 seconds. The best of the three readings was taken and measure was recorded. Scoring cord for the PEFR (applicable in both pre and post test collection of sputum):Amount of PEFR ( lts/min) Points Up to 150 01 150-250 02 250-350 03 350-450 04 More than 450 05 22 SECTION-III OBSERVATION CHECK LIST: Various observation check lists have been developed as there is no availability of standard check lists. These check lists are helpful to observe how correctly the procedure has being conducted, how the patient is following the instructions. Through the observation check list, if the patient can be able to perform the procedure as per the steps, then the values obtained from the procedure can be accepted. X. Methods of data collection After obtaining permission from concerned authority an informed consent from samples, the researcher will collect data from samples. Phase 1 During the selection of samples, every alternative patient was allotted for one group pre test-post test postural drainage on expectoration on mucus from airway. A total of 60 patients were allotted for this postural drainage. Investigator has to develop good rapport with patient and consent was obtained from each patient. Investigator has to collect demographic data. Before administering the postural drainage from each patient, the parameters such as vital signs, sputum expectoration, Peak expiratory flow rate (PEFR) were measured. 23 Phase 2 The patient was given full explanation about postural drainage which will be provided to them in the form of handout or pamphlet and the steps of the procedure how it will be done. Each patient was kept in the position for about 10-15 min and was given rest for 10-15 minutes. If the patient can able to tolerate the position, then the procedure can be repeated again. Phase 3 After completion of the procedure, again the parameters were measured and recorded. XI. Plan for data analysis The data will be analyzed by means of descriptive and inferential statistics. a) Descriptive statistics Mean, median, mode, standard deviation, percentage distribution, will be used to assess the demographic variables. b) Inferential statistics The obtained measures of parameters before administration of postural drainage were tabulated, and ‘t’ test was computed to test the effectiveness of postural drainage. To compare the Sputum production, Peak Exploratory flow rate (PEFR), before and after postural drainage paired ‘t’ test was used. XII. Projected outcomes After the study, the investigator will able to know the ability of patients expectoration of mucus from airway’s with Pneumonia, based on the findings. Postural 24 drainage will be administered to the patients. It will help them to expectoration of mucus more easily. 7.3 Does the study requires any investigation or intervention to the patient or other human being or animal ? No 7.4 Has ethical clearance been obtained from the concerned authority to conduct the study ? Yes a) Permission will be obtained from the Director of selected Hospitals at Bangalore. b) Informed consent will be obtained from the patient with Pneumonia admitted in selected hospitals at Bangalore. to participate in the study with their own knowledge. 25 8. LIST OF REFERENCES 1. API, “Text book of medicine’, seventh edition, 2001, by Gurumukh. S. Sainani, published by Association of Physician of India. Pp: 308-311 . 2. Black M.J. (1997) “Medical Surgical Nursing Clinical Management for th continuity of care”,(5 ed) Philadelphia Saunders Company, Pp :550-567. 3. Cecil, “text book of medicine by Goldman and Bennet”, (2001), vol I&II, 21 st edition, published by Hart court Asia and W.B. Saunders, Pp 790-796. 4. Crofton & Douglas’s Respiratory diseases (2001), vol I&II by Anthony Seaton, th Douglas Seaton, & A. Gordon Leitch, 5 edition, published by Black well science limited, Pp 310-316. 5. Craig L,Scanion, Charles B, Spearman, Richard L. Sheldon (1990) “Egan’s th Fundamentals of Respiratory care” (6 ed), North California. Mosby Company, Pp : 564 6. Craven, R.F. & Constance, J.H. (2000), “Fundamentals of Nursing Human rd Health and Function” (3 ed) Philadelphia Lippincott Company, Pp:178-185 7. Lewis, S.M. Heit Kemper M.L. & Derikson, S.R. (2000), “Medical Surgical Nursing”, Assess men and Management of Clinical Problems (5 th ed) Philadelphia Mosby Company, Pp 545-567. nd 8. Murrary F.J & Nadal A.J. (1998), “Text Book of Respiratory Medicine” (2 ed) Philadelphia W.B. Saunders Company, Pp : 668. st 9. Morgan. M & Singh. S (1997), “Practical pulmonary rehabilitation” (1 edition). London Chapman & Hall medical company, Pp : 359-365. 26 10. Smaltzer C & Susanne (2000), “Brunner and Suddarth text book of Medical th Surgical Nursing” (8 edition) Philadelphia Lippincott Company, Pp : 545. 11. Stoller, J.K (2002) “ Acute Exacerbation of Chronic obstructive pulmonary diseases “ N. Engl J.Med 346,998. 12. Janet S.M., (2000), Pediatric Pulmonology, Volume 27, Issue 1, pages 5–13, http://onlinelibrary.wiley.com/doi/10.1002/(SICI)10990496(199901)27:13.0.CO;2-5/abstract 13. M. Lanari MD, (2002), Pediatric Pulmonology, Volume 33, Issue 6, pages 458– 465, http://onlinelibrary.wiley.com/doi/10.1002/ppul.10047/abstract 14. Gabi Schulgen, (2000), Journal of Clinical Epidemiology, Volume 51, Issue 6, Pages 495-502, http://www.sciencedirect.com/science/article/pii/S0895435698000122 15. Nino Khetsuriani, (2006), Journal of Allergy and Clinical Immunology, Volume 119, Issue 2, Pages 314-321, http://www.sciencedirect.com/science/article/pii/S0091674906021294 16. M.C Kelsey, (2008), Journal of Hospital Infection, Volume 46, Issue 1, Pages 12-22, http://www.sciencedirect.com/science/article/pii/S0195670100907758 17. Carme Puig, (2008), Journal Of Acta Paediatrica, Volume 97, Issue 10, pages 1406–1411, http://onlinelibrary.wiley.com/doi/10.1111/j.1651-2227.2008.00939.x/abstract 18. C. Raherison, (2007), European Respiratory Journal, volume. 19, Page No: 2 314-319, http://erj.ersjournals.com/content/19/2/314.short 27 19. Laurent Kaiser, (2000), Archives of International Medicine, Volume: 163, Page No: 14, http://archinte.ama-assn.org/cgi/content/abstract/163/14/1667 20. Matthias Briel, (2008), Archives of International Medicine, Volume: 168, Page No: 18, http://archinte.ama-assn.org/cgi/content/abstract/168/18/2000 21. E. Michael Sarrell, (2002), Journal Of Respiratory Medicine, volume: 122, Page No. 2015-2020, http://chestjournal.chestpubs.org/content/122/6/2015.short#target-1 22. Brenda M, (2003), Journal Of Chest Physiotherapy, Volume 35, Issue 3, pages 208–213, http://onlinelibrary.wiley.com/doi/10.1002/ppul.10227/abstract 23. Chris L. Kjolhede , (2000), The Journal of Chest Medicin, Volume 126, Issue 5, Page No: 807-812, http://www.sciencedirect.com/science/article/pii/S0022347695704167 24. J E Patterson, (2007), Journal Of Chronic Respiratory Disease, Volume 6, Issue 12, Pages 18-22, http://crd.sagepub.com/content/1/3/127.short 25. B.A. Webber, (2003), British Journal of Diseases of the Chest, Volume 80, Pages 353-359, http://www.sciencedirect.com/science/article/pii/0007097186900884 26. John W. Wong,, (2000), Official Journal Of The American Academy Of Pediatrics, Volume 60, Pages 141-146, http://pediatrics.aappublications.org/content/60/2/146.short 27. J.A. Pryor, (2010), Journal of Cystic Fibrosis, Volume 9, Issue 3, Pages 187192, http://www.sciencedirect.com/science/article/pii/S1569199310000081 28 9. Signature of the candidate : 10. Remarks of the guide : 11. Name and designation of : 11.1 Guide : 11.2 Signature : 11.3 Co-guide : 11.4 Signature : 11.5 Head of the department : 11.6 Signature : 12. Remarks of the Principal : 12.1 Signature :